Yttrium (90Y) tacatuzumab tetraxetan: Difference between revisions

Content deleted Content added

Inline

Revision as of 11:04, 7 October 2009

Tacatuzumab tetraxetan is a humanized monoclonal antibody used to treat cancer.^{[citation needed]} Tacatuzumab it attached to a chelator, tetraxetan, which binds a radioisotope, yttrium-90.^[1]

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

@@ Line 1: / Line 1: @@
-{{drugbox |
+{{drugbox
 | type              = mab
+| source            = [[Human]]
-| image =
-| source = [[Human]]
+| target            = [[α-fetoprotein]]
-| target =
 | CAS_number        = 476413-07-7
 | ATC_prefix        = none
@@ Line 27: / Line 26: @@
 }}
-'''Tacatuzumab tetraxetan''' is a [[Humanize|humanized]] [[monoclonal antibody]] used to treat cancer. Tacatuzumab it attached to a [[chelator]], [[tetraxetan]], and a [[radioisotope]], [[yttrium-90]].
+'''Tacatuzumab tetraxetan''' is a [[Humanize|humanized]] [[monoclonal antibody]] used to treat cancer.{{fact|date=October 2009}} Tacatuzumab it attached to a [[chelator]], [[tetraxetan]], which binds a [[radioisotope]], [[yttrium-90]].<ref>[http://apps.who.int/medicinedocs/documents/s14179e/s14179e.pdf WHO Drug Information]</ref>
+==References==
+{{reflist}}
-{{monoclonal-antibody-stub}}
 {{humanizedmonoclonals}}
@@ Line 35: / Line 36: @@
 [[Category:Articles lacking sources (Erik9bot)]]
 [[Category:Cancer treatments]]
+{{monoclonal-antibody-stub}}